Total Payments
$5,892
2024 Payments
$525.97
Companies
27
Transactions
391
Medicare Patients
8,374
Medicare Billing
$288,295
Payment Breakdown by Category
Food & Beverage$5,882 (99.8%)
Education$10.66 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,882 | 389 | 99.8% |
| Education | $10.66 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,377 | 90 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $941.64 | 59 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $636.96 | 43 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $599.60 | 42 | $0 (2023) |
| PFIZER INC. | $587.57 | 46 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $565.12 | 37 | $0 (2023) |
| GlaxoSmithKline, LLC. | $176.24 | 11 | $0 (2023) |
| Astellas Pharma US Inc | $166.83 | 9 | $0 (2017) |
| Lilly USA, LLC | $154.17 | 11 | $0 (2024) |
| Merck Sharp & Dohme LLC | $149.22 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $525.97 | 23 | AstraZeneca Pharmaceuticals LP ($240.03) |
| 2023 | $177.55 | 10 | Novo Nordisk Inc ($53.96) |
| 2022 | $168.26 | 10 | Boehringer Ingelheim Pharmaceuticals, Inc. ($53.91) |
| 2021 | $228.15 | 12 | Novo Nordisk Inc ($103.81) |
| 2020 | $194.38 | 12 | Novo Nordisk Inc ($54.17) |
| 2019 | $1,189 | 94 | Novo Nordisk Inc ($363.69) |
| 2018 | $1,448 | 101 | Novo Nordisk Inc ($359.65) |
| 2017 | $1,962 | 129 | Janssen Pharmaceuticals, Inc ($346.74) |
All Payment Transactions
391 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: VACCINE | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/16/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Inflammation | ||||||
| 06/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Obesity | ||||||
| 05/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Diabetes | ||||||
| 04/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.78 | General |
| 01/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Diabetes | ||||||
| 01/09/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Diabetes | ||||||
| 12/14/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Oncology | ||||||
| 09/25/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,098 | 2,896 | $210,126 | $77,961 |
| 2022 | 26 | 1,958 | 2,715 | $186,978 | $65,387 |
| 2021 | 30 | 2,041 | 2,903 | $196,903 | $68,621 |
| 2020 | 28 | 2,277 | 3,093 | $225,645 | $76,325 |
Total Patients
8,374
Total Services
11,607
Medicare Billing
$288,295
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 170 | 283 | $55,751 | $19,692 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 102 | 102 | $24,174 | $12,226 | 50.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 29 | 29 | $8,964 | $8,092 | 90.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 159 | $21,147 | $7,768 | 36.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 45 | 45 | $6,480 | $3,411 | 52.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 182 | 254 | $14,478 | $3,321 | 22.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 196 | 298 | $11,324 | $3,060 | 27.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 201 | 357 | $7,497 | $2,999 | 40.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 111 | 111 | $5,106 | $1,878 | 36.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 111 | 111 | $8,769 | $1,878 | 21.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 58 | 60 | $2,160 | $1,706 | 79.0% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 189 | 269 | $8,070 | $1,695 | 21.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 36 | $4,248 | $1,667 | 39.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 92 | 171 | $7,353 | $1,628 | 22.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 19 | 23 | $2,346 | $1,156 | 49.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 31 | 32 | $1,152 | $910.08 | 79.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 12 | 13 | $1,490 | $873.01 | 58.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 44 | 50 | $3,650 | $823.00 | 22.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 47 | 55 | $4,344 | $783.39 | 18.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 90 | 171 | $2,907 | $548.91 | 18.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 14 | 16 | $1,840 | $464.16 | 25.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 41 | 44 | $836.00 | $268.84 | 32.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 30 | 31 | $1,643 | $242.19 | 14.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 41 | 44 | $1,056 | $223.52 | 21.2% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 11 | 11 | $1,012 | $208.12 | 20.6% |
About Dr. Freddie Everson, MD
Dr. Freddie Everson, MD is a Family Medicine healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497728638.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Freddie Everson, MD has received a total of $5,892 in payments from pharmaceutical and medical device companies, with $525.97 received in 2024. These payments were reported across 391 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($5,882).
As a Medicare-enrolled provider, Everson has provided services to 8,374 Medicare beneficiaries, totaling 11,607 services with total Medicare billing of $288,295. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Memphis, TN
- Active Since 02/08/2006
- Last Updated 10/25/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1497728638
Products in Payments
- FARXIGA (Drug) $612.12
- Ozempic (Drug) $524.08
- XARELTO (Drug) $452.79
- TRADJENTA (Drug) $307.91
- Victoza (Drug) $306.25
- Tresiba (Drug) $283.57
- SOLIQUA (Drug) $229.44
- LYRICA (Drug) $215.88
- JARDIANCE (Drug) $197.60
- INVOKANA (Drug) $178.15
- Myrbetriq (Drug) $166.83
- CHANTIX (Drug) $165.00
- TOUJEO (Drug) $153.52
- BEVESPI AEROSPHERE (Drug) $139.20
- SOLIQUA 100/33 (Drug) $108.32
- MOUNJARO (Drug) $107.38
- Rybelsus (Drug) $105.32
- BREO (Drug) $101.17
- VIAGRA (Drug) $97.05
- Edarbi (Drug) $81.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Memphis
Michael Wallace, Md, MD
Family Medicine — Payments: $19,082
Family Medicine $19,082
Jay Smith, M.d, M.D
Family Medicine — Payments: $16,316
Family Medicine $16,316
Dr. Charles Woodall, Md, MD
Family Medicine — Payments: $15,588
Family Medicine $15,588
Dr. Philip Mintz, Md, MD
Family Medicine — Payments: $13,885
Family Medicine $13,885
Dr. Fang Zhou, M.d, M.D
Family Medicine — Payments: $13,292
Family Medicine $13,292
Melanie Woodall, Md, MD
Family Medicine — Payments: $12,818
Family Medicine $12,818